CD8 T Cell Exhaustion in Chronic Infection and Cancer: Opportunities for Interventions

被引:454
作者
Hashimoto, Masao [1 ,2 ]
Kamphorst, Alice O. [1 ,2 ]
Im, Se Jin [1 ,2 ]
Kissick, Haydn T. [1 ,2 ,3 ]
Pillai, Rathi N. [4 ]
Ramalingam, Suresh S. [4 ]
Araki, Koichi [1 ,2 ]
Ahmed, Rafi [1 ,2 ]
机构
[1] Emory Univ, Sch Med, Emory Vaccine Ctr, Atlanta, GA 30322 USA
[2] Emory Univ, Sch Med, Dept Microbiol & Immunol, Atlanta, GA 30322 USA
[3] Emory Univ, Sch Med, Dept Urol, Atlanta, GA 30322 USA
[4] Emory Univ, Sch Med, Winship Canc Inst, Dept Hematol & Med Oncol, Atlanta, GA 30322 USA
来源
ANNUAL REVIEW OF MEDICINE, VOL 69 | 2018年 / 69卷
关键词
T cell exhaustion; PD-1; checkpoint inhibitors; chronic infection; cancer; immunotherapy; CHRONIC VIRAL-INFECTION; PD-1; BLOCKADE; INHIBITORY RECEPTORS; ANTI-PD-L1; ANTIBODY; COMBINED NIVOLUMAB; VIRUS-INFECTION; TUMOR; EFFECTOR; IMMUNOTHERAPY; IPILIMUMAB;
D O I
10.1146/annurev-med-012017-043208
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Antigen-specific CD8 T cells are central to the control of chronic infections and cancer, but persistent antigen stimulation results in T cell exhaustion. Exhausted CD8 T cells have decreased effector function and proliferative capacity, partly caused by overexpression of inhibitory receptors such as programmed cell death (PD)-1. Blockade of the PD-1 pathway has opened a new therapeutic avenue for reinvigorating T cell responses, with positive outcomes especially for patients with cancer. Other strategies to restore function in exhausted CD8 T cells are currently under evaluation-many in combination with PD-1-targeted therapy. Exhausted CD8 T cells comprise heterogeneous cell populations with unique differentiation and functional states. A subset of stem cell-like PD-1(+) CD8 T cells responsible for the proliferative burst after PD-1 therapy has been recently described. A greater understanding of T cell exhaustion is imperative to establish rational immunotherapeutic interventions.
引用
收藏
页码:301 / 318
页数:18
相关论文
共 107 条
  • [31] Gros A, 2014, J CLIN INVEST, V124, P2246, DOI [10.1172/JCI73639, 10.1172/JC173639]
  • [32] Follicular CXCR5-expressing CD8+ T cells curtail chronic viral infection
    He, Ran
    Hou, Shiyue
    Liu, Cheng
    Zhang, Anli
    Bai, Qiang
    Han, Miao
    Yang, Yu
    Wei, Gang
    Shen, Ting
    Yang, Xinxin
    Xu, Lifan
    Chen, Xiangyu
    Hao, Yaxing
    Wang, Pengcheng
    Zhu, Chuhong
    Ou, Juanjuan
    Liang, Houjie
    Ni, Ting
    Zhang, Xiaoyan
    Zhou, Xinyuan
    Deng, Kai
    Chen, Yaokai
    Luo, Yadong
    Xu, Jianqing
    Qi, Hai
    Wu, Yuzhang
    Ye, Lilin
    [J]. NATURE, 2016, 537 (7620) : 412 - +
  • [33] Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
    Hodi, F. Stephen
    O'Day, Steven J.
    McDermott, David F.
    Weber, Robert W.
    Sosman, Jeffrey A.
    Haanen, John B.
    Gonzalez, Rene
    Robert, Caroline
    Schadendorf, Dirk
    Hassel, Jessica C.
    Akerley, Wallace
    van den Eertwegh, Alfons J. M.
    Lutzky, Jose
    Lorigan, Paul
    Vaubel, Julia M.
    Linette, Gerald P.
    Hogg, David
    Ottensmeier, Christian H.
    Lebbe, Celeste
    Peschel, Christian
    Quirt, Ian
    Clark, Joseph I.
    Wolchok, Jedd D.
    Weber, Jeffrey S.
    Tian, Jason
    Yellin, Michael J.
    Nichol, Geoffrey M.
    Hoos, Axel
    Urba, Walter J.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2010, 363 (08) : 711 - 723
  • [34] T cell costimulatory receptor CD28 is a primary target for PD-1-mediated inhibition
    Hui, Enfu
    Cheung, Jeanne
    Zhu, Jing
    Su, Xiaolei
    Taylor, Marcus J.
    Wallweber, Heidi A.
    Sasmal, Dibyendu K.
    Huang, Jun
    Kim, Jeong M.
    Mellman, Ira
    Vale, Ronald D.
    [J]. SCIENCE, 2017, 355 (6332) : 1428 - +
  • [35] Defining CD8+ T cells that provide the proliferative burst after PD-1 therapy
    Im, Se Jin
    Hashimoto, Masao
    Gerner, Michael Y.
    Lee, Junghwa
    Kissick, Haydn T.
    Urger, Matheus C. B.
    Shan, Qiang
    Hale, J. Scott
    Lee, Judong
    Nasti, Tahseen H.
    Sharpe, Arlene H.
    Freeman, Gordon J.
    Germain, Ronald N.
    Nakaya, Helder I.
    Xue, Hai-Hui
    Ahmed, Rafi
    [J]. NATURE, 2016, 537 (7620) : 417 - +
  • [36] Exhausted CD8 T Cells Downregulate the IL-18 Receptor and Become Unresponsive to Inflammatory Cytokines and Bacterial Co-infections
    Ingram, Jennifer T.
    Yi, John S.
    Zajac, Allan J.
    [J]. PLOS PATHOGENS, 2011, 7 (09)
  • [37] Involvement of PD-L1 on tumor cells in the escape from host immune system and tumor immunotherapy by PD-L1 blockade
    Iwai, Y
    Ishida, M
    Tanaka, Y
    Okazaki, T
    Honjo, T
    Minato, N
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (19) : 12293 - 12297
  • [38] CXCR5+ CD8+ T Cells Indirectly Offer B Cell Help and Are Inversely Correlated with Viral Load in Chronic Hepatitis B Infection
    Jiang, Hang
    Li, Linhai
    Han, Jiang
    Sun, Zhiwei
    Rong, Yihui
    Jin, Yun
    [J]. DNA AND CELL BIOLOGY, 2017, 36 (04) : 321 - 327
  • [39] Role of IL-2 in cancer immunotherapy
    Jiang, Tao
    Zhou, Caicun
    Ren, Shengxiang
    [J]. ONCOIMMUNOLOGY, 2016, 5 (06):
  • [40] Cooperation of Tim-3 and PD-1 in CD8 T-cell exhaustion during chronic viral infection
    Jin, Hyun-Tak
    Anderson, Ana C.
    Tan, Wendy G.
    West, Erin E.
    Ha, Sang-Jun
    Araki, Koichi
    Freeman, Gordon J.
    Kuchroo, Vijay K.
    Ahmed, Rafi
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2010, 107 (33) : 14733 - 14738